SCHEMBL249600

SCHEMBL249600

O=P(O)(O)CC(CP(=O)(O)O)(P(=O)(O)O)P(=O)(O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
MMP2 P08253 1/20 0.39
THRB P10828 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GGPS1 O95749 5/20 0.39
TYMS P04818 1/20 0.35
LMNA P02545 3/20 0.33
FDPS P14324 4/20 0.32
ADRB3 P13945 1/20 0.32
PDE4D Q08499 1/20 0.32
PDE3A Q14432 1/20 0.32
MEN1 O00255 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
BLM P54132 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
PGK1 P00558 1/20 0.32
PGK2 P07205 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19211976 0.83 GGPS1 (0.43) GGPS1LMNAFDPS
SCHEMBL597134 0.77 LMNA (0.33) KDM4EMMP2THRBMAPK1HSD17B10
SCHEMBL10784249 0.73 KDM4E (0.39) KDM4EMMP2THRBMAPK1HSD17B10
SCHEMBL6659016 0.72 KDM4E (0.44) KDM4EMMP2THRBMAPK1HSD17B10
SCHEMBL11746955 0.71 FDPS (0.43) KDM4EMMP2THRBMAPK1HSD17B10
SCHEMBL3144201 0.71 FDPS (0.48) GGPS1LMNAFDPSADRB3PDE4D
SCHEMBL8899019 0.71 LMNA (0.38) KDM4EMMP2THRBMAPK1HSD17B10
SCHEMBL10941191 0.69 LMNA (0.43) KDM4EMMP2THRBMAPK1HSD17B10
SCHEMBL8337169 0.69 FDPS (0.41) KDM4EMMP2THRBMAPK1HSD17B10
SCHEMBL16168096 0.69 LMNA (0.43) KDM4EMMP2THRBMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3413934-B1 IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS NANO BRIDGING MOLECULES SA (CH) 2021-10-13 EP claimed
CN-109195641-B Improved implant treatment with phosphonic acid compounds 纳米桥接分子股份公司 2021-07-27 CN claimed
US-11000627-B2 Treatment of implants with phosphonic acid compounds NANO BRIDGING MOLECULES SA (CH) 2021-05-11 US claimed
US-20190038802-A1 IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS NANO BRIDGING MOLECULES SA (CH) 2019-02-07 US claimed
EP-3413934-A1 IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS Nano Bridging Molecules SA (CH) 2018-12-19 EP claimed
WO-2017137623-A1 IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS NANO BRIDGING MOLECULES SA (CH) 2017-08-17 WO claimed
US-6281178-B1 PREVENT FILMING AND/OR STREAKING AFTER A SURFACE IS CLEANED WITH THE COMPOSTIONS. STEPAN COMPANY 2001-08-28 US claimed
US-4240920-A A SURFACTANT, A PEROXY BLEACH AND A PORPHINE BLEACH THE PROCTER & GAMBLE COMPANY (US) 1980-12-23 US claimed
US-12529014-B2 Polyurethane redeposition inhibiting polymers and detergent compositions containing same LUBRIZOL ADVANCED MATERIALS, INC. (US) 2026-01-20 US disclosed
US-12460160-B2 Redeposition inhibiting styrene maleic anhydride copolymers and detergent compositions containing same LUBRIZOL ADVANCED MATERIALS, INC. (US) 2025-11-04 US disclosed
US-12311320-B2 Use of extended surfactants in process membrane cleaning ECOLAB USA INC. (US) 2025-05-27 US disclosed
EP-4077612-B1 REDEPOSITION INHIBITING POLYMERS AND DETERGENT COMPOSITIONS CONTAINING SAME LUBRIZOL ADVANCED MAT INC (US) 2023-12-06 EP disclosed
US-20230357673-A1 REDEPOSITION INHIBITING POLYMERS AND DETERGENT COMPOSITIONS CONTAINING SAME LUBRIZOL ADVANCED MATERIALS, INC. (US) 2023-11-09 US disclosed
US-20230017803-A1 Redeposition Inhibiting Polymers And Detergent Compositions Containing Same LUBRIZOL ADVANCED MATERIALS, INC. (US) 2023-01-19 US disclosed
US-3986986-A DETERGENTS LEVER BROTHERS COMPANY (US) 1976-10-19 US disclosed
US-3979339-A POLYVINYL PYRROLIDONE, VINYL ACETATE-VINYL ALCOHOL COPOLYMER THE PROCTER & GAMBLE COMPANY (US) 1976-09-07 US disclosed
US-3970594-A SURFACTANT, BUILDER, POLYVINYL ALCOHOL OR PYRROLIDONE, POLYSACCHARIDE THE PROCTER & GAMBLE COMPANY (US) 1976-07-20 US disclosed
US-3940433-A SURFACTANTS, DETERGENTS LEVER BROTHERS COMPANY (US) 1976-02-24 US disclosed
US-3939100-A Combination alkali metal pyrophosphate-alkaline earth metal pyrophosphate detergent builder THE PROCTER & GAMBLE COMPANY (US) 1976-02-17 US disclosed
US-3932316-A PHOSPHATE-FREE THE PROCTER & GAMBLE COMPANY (US) 1976-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12529014-B2 Polyurethane redeposition inhibiting polymers and detergent compositions containing same PUF60, XRCC6, SDC2 KDM4E 273/4885MMP2 549/4885THRB 3880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.